GPRC5D

Myeloma Treatments

The following is a listing of myeloma treatments associated with this tag.

View All
Multiple Myeloma

All Treatments

View all treatments in development for myeloma patients around the US.

BMS-986393 (CC-95266)

View Treatment

Talquetamab Talvey^®

View Treatment

Early Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.

Talquetamab Talvey^®

View Treatment

Late Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.

BMS-986393 (CC-95266)

View Treatment

Talquetamab Talvey^®

View Treatment

Myeloma Clinical Trials

The following is a listing of myeloma clinical trials associated with this tag.

All Clinical Trials

View all active clinical trials around the US.

Verified

A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants With Relapsed an...

CA088-1005

View Trial

Verified

A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or R...

BMS-986453

View Trial

Verified

A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma

MONUMENTAL-8

View Trial

Verified

A Phase 2, Open-label, Randomized Study to Evaluate Prophylactic Interventions on Talquetamab-related Oral Toxicity

TALISMAN

View Trial

Verified

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

MONUMENTAL-1

View Trial

Verified

Phase 2 Study of BMS-986393, a GPRC5D-directed CART-Cell Therapy, in Participants with Relapsed or Refractory Multiple Myeloma

QUINTESSENTIAL

View Trial

Verified

Phase 3 Clinical Trial Comparing the Efficacy of an Investigational Medication Combined with Daratumumab or Daratumumab and Pomalidomide Versus Daratumumab, ...

MONUMENTAL-3

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab VS Lenalidomide in Participants with Newly Diagnosed Multiple Myeloma Who Have H...

MAGNETISMM-7

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

A Phase 1/2 Open Label Study to Evaluate the Safety and Efficacy of CT071, an Autologous Anti-GPRC5D CAR T,...

CT071

View Trial

A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection An...

REDIRECTT-1

View Trial

A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedul...

RADIATION + TALQUETAMAB FOR EXTRAMEDULLARY DISEASE

View Trial

A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Au...

AMMBITION

View Trial

A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in C...

MONUMENTAL-6

View Trial

A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of BMS-986393, a GP...

QUINTESSENTIAL-2

View Trial

A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and...

ORICAR-017 - RIGEL STUDY

View Trial

A Phase Ib, Multi-center, Study of Talquetamab in Combination With Iberdomide and Dexamethasone for the Tre...

TALQUETAMAB WITH IBERDOMIDE

View Trial

An Open-Label, Non-Randomized, Multicenter, Phase II Study to Study the Efficacy of Talquetamab (JNJ-644075...

OPTIMMAL

View Trial

An Open-Label, Randomized Phase IB/II Study Evaluating Safety, Tolerability, and Clinical Activity of Forim...

FORIMTAMIG

View Trial

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory M...

AZD0305

View Trial

Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma (MonumenT...

MONUMENTAL-1

View Trial

Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants Wit...

JNJ-79635322

View Trial

Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma

TALQUETAMAB CONSOLIDATION AFTER BCMA CAR-T

View Trial

Teclistamab or Talquetamab in Combination With Daratumumab SC for High-Risk Smoldering Myeloma: A Clinical ...

REVIVE

View Trial

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Verified